Abstract OBJECTIVE: To determine if the use of non-diabetes-related preventive services (mammography, colorectal cancer screening and bone density testing) among elderly diabetic women is different than the use among women without diabetes. RESEARCH DESIGN AND METHODS: Using a representative sample of the U.S. elderly female population, the linked SEER/Medicare files, we identified women with or without diabetes who were > 67 years of age on January 1, 1999. All women with a prior history of cancer were excluded. Bivariate and multivariate analyses were employed to compare the rates of preventive service use and understand the factors influencing their use in the next two to four years. RESULTS: Women with diabetes were less likely to have a mammogram (OR = 0.83, 95% CI: 0.78 -0.88), colorectal cancer screening (OR = 0.79, 95% CI: 0.70 -0.88), and bone density testing (OR = 0.63, 95% CI: 0.58 -0.69). Women with diabetes seen by endocrinologists had significantly higher rates of bone density testing than women seen by primary care physicians. Women seen by obstetrician-gynecologists had the highest rates of use of all three services. CONCLUSIONS: Elderly women with diabetes are less likely to receive cancer and osteoporosis screening than women without diabetes. Physicians treating these patients need to assure that they receive all recommended preventive services appropriate for their age. Additional national guidelines, practice-based improvements, and patient education targeting those at greatest risk to not receiving these services may be needed in order to achieve parity.
Increasing use of diabetes preventive services (HbA 1c and serum lipid monitoring, proteinuria assessment, and dilated eye and foot examination) recommended by the American Diabetes Association (ADA) and others are now frequently reported by the National Centers For Disease Control and Prevention (CDC) and other researchers (1) (2) (3) (4) (5) (6) (7) (8) . Less frequently reported is the use of other recommended preventive services appropriate for the entire population, including those with diabetes, such as cancer and osteoporosis screening. Tabie et al. reported that 73% of diabetic women in managed care plans in Michigan had mammograms and 56% had Pap smears in the prior 2 or 3 years, respectively. Increased use of diabetes process and quality of care measures were associated with increased use of these two screening services (9) . Mammography and Pap smear use in women without diabetes was not reported. Comparing Ontario women between 50 and 67 years of age with diabetes to those without diabetes, Lipscombe et al. found a significantly lower rate of biennial mammography use among the women with diabetes (adjusted OR = 0.68; 95% CI: 0.67 -0.69) (10) .
This study examines the use of mammography in a larger U.S. population of women with diabetes, as well as two other preventive services: screening for colorectal cancer and bone density testing.
Research Design and Methods
The primary source of data was the Sumdenom file from the merged Surveillance Epidemiology and End Results (SEER)-Medicare data files created in 2003 (11) . This file contains a random sample of 5% of women > 65 years of age living in the SEER areas who had no history of cancer from 1973 through 1999 (n = 109,138). Further, we used the Medicare claims files to exclude women who developed cancer from 2000 through 2002, the end of our study period (n = 9,700). This resulted in 99,438 available women.
Consistent with other studies using Medicare data, we excluded those beneficiaries who did not have both Medicare Part A and Part B (n = 7,909), were enrolled in managed care (n = 31,781) or a hospice program (n = 2,541), had end-stage renal disease (n = 39), or did not reside in the SEER areas during the entire study period (n = 2,626). This resulted in 54,542 eligible women.
Medicare claims data from 1997 and 1998 were used to identify women with diabetes on January 1, 1999. We used our validated algorithm (12) that we recently reported had a sensitivity of 90%, a specificity of 97%, and a positive predictive value of 93% for identifying Medicare beneficiaries with diabetes (13). 8,232 women > 67 years of age were identified as having diabetes.
Medicare National Claims History (NCH) and Outpatient files were used to determine the study outcomes: 1999 and 2000 for mammography and bone density testing, and 1999 through 2002 for colorectal cancer screening. These periods were based on Medicare reimbursement policy: 24 months for bone density testing, and 48 months for colorectal cancer screening; or the commonly used period in the literature for evaluating mammography, 24 months. In addition to age and race, two other covariates that could influence the use of these services were obtained from the Sumdenom file: Medicaid program participation and rural residence. The 2000 U.S. Census Bureau ST3 file was used to determine the median household income for each person's zip code of residence. The Medicare claims files from 1997 and 1998 were used to determine if a person had been hospitalized, and if hospitalized, whether in a teaching or a non-teaching hospital; the specialties of physicians providing care to the beneficiary; comorbidities; and the average annual number of physician visits.
Using the specialty identification codes available in the Medicare data, physicians were grouped into primary care (01 = general practice, 08 = family practice, 11 = internal medicine, 38 = geriatric medicine, and 70 = multi-specialty group practice); obstetrics-gynecology (16 = obstetrics-gynecology); endocrinology (46 = endocrinologist); and other (all other provider codes). If a woman was ever seen by an endocrinologist or if ever seen by an obstetrician-gynecologist, she was put in the appropriate group. If she was seen by both of these specialists, she was put in the endocrinologist + obstetriciangynecologist group. Among the remaining women, those seen by a primary care physician were put in that group. Those women not included in the prior groups were put into the category "Other" which included women who had no physician visit in 1997 or 1998 (< 1%), also.
Consistent with the recommendation of Klabunde et al. (14), we examined the Medicare files to identify comorbidities and used the Charlson Index to categorize and weight them. Because all persons with diabetes would have a Charlson score > 1, diabetes was excluded when calculating the Charlson scores.
As a measure of diabetes preventive service use, we adopted the method of Tabie et al. (9) and simply summed the diabetes preventive services received by diabetic women in 1997 and 1998 that we could measure using the Medicare administrative data (HbA 1c and LDLcholesterol testing, and eye examination).
We used the propensity score matching method to create an appropriate comparison population of women with no history of diabetes (15). These latter women were also identified in the SEERMedicare Sumdenom file. The propensity score for having diabetes, or not, for each woman was obtained from logistic regression in which all of the co-variables mentioned above were used as predictors. Each woman with diabetes was matched with an elderly women without diabetes living in the same SEER area whose propensity score was nearest to that of the person with diabetes but within 0.5 of the standard deviation of the score of the person with diabetes (one-to-one nearest neighbor method). The psmatch2 module in Stata 9.1 was used for this matching procedure (16).
Analyses were performed on the matched cohorts (8, 197 in each group). Univariate and bivariate analysis were performed to describe and compare the populations and their use of services. Differences between cohorts were tested using the Z-test. Multivariate logistic regression analyses were carried out on the cohort of women with diabetes for each preventive service in order to examine the impact of the covariates described above on the receipt of each service while simultaneously adjusting for the others. To adjust for possible geographical difference between SEER areas, we used the Generalized Estimate Equation model with geographic areas as the cluster variable. Differences were judged statistically significant if the 95% confidence interval (CI) did not include 1.00. All statistical analyses used the Statistical Analysis Software (SAS GENMOD, version 9.1 for Windows, SAS Institute Inc., Cary, NC, 2006).
Results
The distributions of the demographic, clinical and health service characteristics of those with diabetes and the comparison population were similar, except that even after the propensity score matching, a slightly higher percentage of women without diabetes were seen by primary care physicians (Table 1) .
Women with diabetes were less likely than those without diabetes to receive each of the three services ( Table 2 ). The crude and age-adjusted rate ratios (women with diabetes/women without diabetes) were 0.92 for mammography, 0.83 for colorectal cancer screening, and 0.70 for bone density testing (p < 0.0001 for each service). Multivariate analysis which included all women in the study and adjusted for all of the covariates in Table  2 confirmed all three findings with significantly different adjusted odds ratios of 0.83 (95% CI: 0.78-0.88) for mammography; 0.79 (95% CI: 0.70-0.88) for colorectal screening; and 0.63 (95% CI: 0.58-0.69) for bone density testing.
For the two cancer screening tests, the age-adjusted rates among diabetic women were significantly lower for almost all of the patient and health service characteristics compared with the rates among those without diabetes. The only exceptions were for those subgroups which tended to have the lowest rates: women 85 years of age and older, those of black or 'other' race/ethnicity, those in a state Medicaid operated programs, and those seen by "other" physicians ( Table  2 ). For bone density testing, the ageadjusted rates were significantly lower for all of the subcategories of patient and health service characteristics among women with diabetes compared with those without diabetes. For those patient and health services characteristics in which significant differences (p < 0.05) in the age-adjusted rates were found between those with diabetes and those without, the rates among those with diabetes were generally between 65% and 77% of the rates among the women without diabetes.
Among diabetic women, having visited an endocrinologist and/or an obstetriciangynecologist increased the use of each of the preventive services compared with visiting only primary care physicians. Among women with diabetes, ageadjusted mammography rates were 14% greater among women who had seen an endocrinologist, 40.7/100, than among women who had seen primary care physicians, 35.9/100 (p = 0.0418). Women with diabetes who saw endocrinologists were 78% more likely to have bone density testing (19.7/100 versus 11.1/100, p < 0.0001), but no more likely to have colorectal cancer screening. However, those women with diabetes who visited an obstetrician-gynecologist had the highest rates of use all three preventive services. Compared with those who saw only primary care physicians, the rates were 69% higher for mammography, 59% higher for colorectal cancer screening and twice as great for bone density testing (p < 0.0001 for each comparison). They were 49%, 50% and 12% higher, respectively, among those who saw an obstetrician-gynecologist compared with those who saw an endocrinologist (p < 0.0001, p = 0.0001, and p = 0.3058, respectively). The rates among those few women who visited both an endocrinologist and an obstetriciangynecologist were not significantly different from the rates among those who saw only an obstetrician-gynecologist.
The multivariate analysis performed only on those women with diabetes (Table 3) , confirmed the importance of visiting an obstetrician-gynecologist compared with only visiting a primary care physician in order to achieve the highest rates of preventive service use. The adjusted relative odds of receiving a service among those who visited an obstetriciangynecologist ranged from 1.57 for colorectal screening to 2.80 for mammography. Only for bone density testing did visiting an endocrinologist result in significantly increased use of service over visiting only primary care physicians.
The multivariate model showed the following consistent results across all three screening rates: they decreased with age; and they were lower for those in a state Medicaid program administered programs, were hospitalized in the prior two years, had the highest Charlson scores, had <5 physician visits per year in the prior two years compared with those with more visits, or did not have any diabetes preventive service in the prior two years. In addition, there were significant decreasing trends for all three services with increasing Charlson scores. Increasing trends were associated with an increasing number of physician visits and with receiving an increasing number of diabetes preventive services.
Conclusions
The dominant finding is that elderly women with diabetes had significantly lower preventive health service utilization rates than women without diabetes. The lower use of these three preventive services are important findings because women with diabetes are reported to be at higher risk for colorectal cancer incidence and mortality (17, 18), and they face the same risks for breast cancer and osteoporosis. The most striking positive finding among those with diabetes was the association of receiving care from an obstetrician-gynecologist with the highest rates of preventive service use. (20) . While this might explain differences we found for mammography and bone density testing, it would not apply to our findings regarding colorectal cancer screening. Also, deferring this care to obstetriciangynecologists would not be good policy or practice for the elderly because we found that only 12% of elderly women visited an obstetrician-gynecologist over a two-year period. Thus, leaving screening or screening motivation/scheduling to obstetrician-gynecologists, would be inadequate. Receipt of cancer screening care scheduling or motivation from endocrinologists would not solve the problem either because too few women with diabetes, 6.0%, were seen by endocrinologists. If we are to achieve the "best practice" levels of care seen in women who were treated by obstetriciangynecologists, then the use of these services will have to be promoted more effectively by primary care physicians and others. While we found the strongest associations with visiting an obstetriciangynecologist, we are reluctant to attribute causality because it may be that the women who see, or seek, these physicians may be more prevention oriented. Nonetheless, our study met the criteria recently listed for addressing selection bias in studies such as ours (21).
Among women with diabetes, perhaps the most disturbing finding was that those who were in Medicaid administered programs were only about two-thirds as likely to receive any of the services ( Table  2 ). The relative odds in the multivariate analysis were similar: 0.56 for mammography; 0.77 for colorectal screening, and 0.67 for bone density testing (Table 3) . Women in these programs are likely to be nursing home residents with multiple chronic conditions with fewer visits to endocrinologists or obstetrician-gynecologists which might explain the lower age-adjusted rates. However, this would not explain why there was such a large difference after adjusting for all the covariates.
It is not surprising that the use of the screening services declined with age. This has been reported for mammography (22) and bone density testing (23), and it likely reflects the strict adherence to guidelines published organizations other than CMS for mammography, as well as patient and physician preferences. Bynum et al. reported that health status, as measured by the propensity to die, was independently associated with screening mammography use in the Medicare population (22). In our fully adjusted analysis, we, too, found that those with the highest Charlson scores were significantly less likely to receive any of the three services (adjusted odds ratios of 0.65 for mammography, 0.81 for colorectal cancer screening, and 0.84 for bone density testing). The major strengths of this paper include the large size of the population studied, the use of SEER areas that are representative of the U.S. population, the accuracy of the SEER diagnoses, and the ability to exclude women with histories of breast and colorectal cancer from the study. These latter women would likely have had mammograms or colorectal tests that were part of follow-up for their cancer that would not be screening examinations. Excluding these women increased the probability that the tests we counted were truly for screening. An additional strength of the study is the propensity score matching made the diabetes and non-diabetes study groups more comparable in terms of the observable characteristics than had that not been done. Thus, the differences we found between these two groups in the utilization of preventive services were more likely due to having diabetes, and less likely due to potential confounders. Our study could be strengthened in several ways. Because of data limitations, we were obliged to use zip code-level rather than individual-level income information which introduces the possibility of ecologic bias. Also, we did not have information to measure practice characteristics such as size, volume, the use of information systems, or the availability of diabetes care management programs.
In conclusion, elderly women with diabetes are less likely than women without diabetes to receive the three recommended preventive services we examined. If we are to achieve parity, then it may be necessary to issue additional guidelines emphasizing preventive care and initiate practice-based improvements targeting those at greatest risk to not receiving these services. 
